Alnylam Pharmaceuticals Inc
(LTS:0HD2)
$
215.17
-4.99 (-2.27%)
Market Cap: 29.33 Bil
Enterprise Value: 27.29 Bil
PE Ratio: 40.74
PB Ratio: 21.65
GF Score: 69/100 Sorry the transcript is not found. Please try another one.